For Immediate Assistance Call 1-800-966-2244

Month: May 2019

News

84-Year-Old With Mesothelioma Wins Case Against Asbestos Company

An Australian judge hearing the case of an 84-year-old man diagnosed with malignant mesothelioma put a stop to an asbestos company’s arguments against having to pay for his care at home, saying that the man has a right to some comfort in his final days. Judge Wendy Strathdee of the Dust Diseases Tribunal of New South Wales was hearing the case of Ronald William Phillips, a former architectural designer whose asbestos-related disease has been blamed on contaminated products sold by James Hardie. The previously active octogenarian had been living on his own in a beachside town prior to his diagnosis, then moved to a rented apartment where he has been receiving nursing care from professionals, family and friends. But James Hardie company attorneys objected to the expense and insisted that they only should have to pay for care at a nursing home. The judge rejected their argument.

read more
News

TTF Therapy Receives FDA Approval for Mesothelioma Victims

Victims of asbestos exposure who have been diagnosed with malignant mesothelioma received some promising medical news last week when the U.S. Food and Drug Administration approved Novocure’s NovoTTF-100L System for treatment of their rare and fatal disease. The approval is the first that the federal agency has given to a malignant mesothelioma treatment in fifteen years.

read more
News

Mesothelioma Lawsuits Against Consumer Talc Companies Continue

The mesothelioma lawsuit filed by Patricia Schmitz against Johnson & Johnson’s Baby Powder continued in a California court room this week, with a pulmonologist brought in by the consumer giant claiming that the 61-year-old woman’s mesothelioma was not caused by exposure to asbestos: instead, he claims that it generated spontaneously. The same expert claimed that there is no causal relationship between ambient asbestos exposure and the terminal asbestos-related disease.

read more
News

Lung Specialist Gives Heartbreaking Testimony in 61-Year-Old’s Mesothelioma Lawsuit

Every mesothelioma lawsuit represents a tragedy. Each one tells the story of a person who, at some point in their life, was exposed to asbestos, and that exposure results in them being diagnosed with a painful and incurable form of terminal cancer. Still, some cases are more emotionally challenging than others, and such is the case of 61-year-old Patricia Schmitz. Schmitz is seeking compensation from both Johnson & Johnson’s and Colgate-Palmolive, accusing both of knowing that asbestos was contaminating their talc-based products and hiding that information from the public. 

read more
News

St. Croix Mesothelioma Victims Still Seek Justice After Decades of Delay

When you think of mesothelioma victims, you rarely imagine them in a tropical paradise setting, but that is exactly the case for hundreds of former employees of the Hess Oil refinery in St. Croix, as well as their spouses and residents who lived in the refinery’s vicinity. According to a report published in the St. Croix Source,there are more than 600 long-standing asbestos cases waiting to be heard in the St. Croix courts, and the victims may finally be getting closer to having their claims resolved.

read more
News

Hoping to Stop Mesothelioma, New Jersey Takes Lead in Asbestos Ban

More than 40 years ago, researchers in New Jersey published one of the first studies linking exposure to asbestos to malignant mesothelioma, and many Americans believe that since that time use of the material has been entirely banned in the United States. Unfortunately, this is not correct: the powerful chemical industry lobby has worked against a ban for decades, with its most recent victory coming last week when the U.S. Environmental Protection Agency issued a new rule that it claims limits the use of the carcinogenic material, but which health advocates say fall far short of an actual ban. In response, the state of New Jersey has issued its own state-wide ban of asbestos, and one of its representatives to Congress is moving to do the same nationally.

read more
News

Asbestos Experts Warnings Give Rise to Fears of Mesothelioma in Durham, NC

We all know that asbestos has been tied to malignant mesothelioma and other serious and deadly illnesses, so avoiding exposure to the carcinogenic material is something that just makes good sense. With that in mind, consider the quandary faced by those living in the immediate vicinity of the April 10thexplosion in Durham, North Carolina. Where city officials are giving every indication that there is no cause for concern and no risk of asbestos exposure, a former EPA employee who helped advise cleanup crews at the World Trade Center after 9/11 is urging caution, and said that she herself would not venture near the area out of fear of exposure.

read more
News

Mesothelioma Patients Deserve Reimbursement for Palliative Care

People diagnosed with malignant mesothelioma require immediate, expert medical attention from physicians who have experience in treating this rare and fatal form of cancer. Where cancer treatments have traditionally focused on battling the disease itself, an increasing number of cancer treatment centers are also offering their patients additional services designed to provide much-needed emotional support and pain relief, and this additional approach is making a very big difference for patient quality of life.

read more
News

Mesothelioma Lawsuit Jury Hears Testimony from Microscope Researcher

An expert who has dedicated his professional life to investigating the presence of asbestos in a variety of materials gave testimony in a mesothelioma lawsuit this week indicating that he had identified the carcinogenic material in both Colgate-Palmolive’s Cashmere Bouquet facial powder and Johnson & Johnson’s Baby Powder.  Microscope researcher Dr. William Longo of Georgia was testifying in California on behalf of Patricia Schmitz, a woman who claims that her 40-year use of both products is what led to her being diagnosed with the rare and fatal form of cancer.

read more